STOCK TITAN

CONEXEU SCIENCES (CNXU) Stock Price, News & Analysis

CNXU NASDAQ

Company Description

CONEXEU SCIENCES (NASDAQ: CNXU) is a publicly traded biotechnology company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies sector. The company has a market capitalization of $276.7M, ranking #4,357 among all listed U.S. companies by market cap.

CNXU stock has declined 27.3% over the past year, placing it at #3,694 in year-to-date performance among tracked companies. Shares last traded at $9.50.

This page provides a comprehensive overview of CNXU stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$9.52
-7.93%
0.82
Last updated: July 14, 2026 at 15:59
-27.31%
Performance 1 year
$276.7M

CONEXEU SCIENCES (CNXU) stock last traded at $9.50, down 7.93% from the previous close. Over the past 12 months, the stock has lost 27.3%. At a market capitalization of $276.7M, CNXU is classified as a micro-cap stock with approximately 26.8M shares outstanding.

See what a $1,000 investment in CNXU would be worth today

SEC Filings

CONEXEU SCIENCES has filed 5 recent SEC filings, including 3 Form 3, 1 Form 4, 1 Form 8-K. The most recent filing was submitted on July 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CNXU SEC filings →

Insider Radar

Net Buyers
90-Day Summary
405,000
Shares Bought
0
Shares Sold
2
Transactions
Most Recent Transaction
Purcell Lynn Sebastian (Director) bought 202,500 shares @ $0.80 on June 18, 2026

Insider buying activity at CONEXEU SCIENCES over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

JAN
01
January 1, 2027 - March 31, 2027 Regulatory

510(k) FDA submission

Targeted 510(k) FDA submission for CXU wound care device in Q1 2027; CDMO scale-up, packaging and sterilization work.
JAN
01
January 1, 2027 - March 31, 2027 Regulatory

510(k) submission

Targeting 510(k) submission for lead CXU™ candidate via predicate pathway in Q1 2027; subject to testing, manufacturing.

CONEXEU SCIENCES has 2 upcoming scheduled events. The next event, "510(k) FDA submission", is scheduled for January 1, 2027 (in 170 days). Investors can track these dates to stay informed about potential catalysts that may affect the CNXU stock price.

Short Interest History

Last 12 Months

Short interest in CONEXEU SCIENCES (CNXU) currently stands at 25.5 thousand shares, up 18.1% from the previous reporting period, representing 0.2% of the float. Over the past 12 months, short interest has increased by 18.0%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for CONEXEU SCIENCES (CNXU) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

CNXU Company Profile & Sector Positioning

CONEXEU SCIENCES (CNXU) operates in the Biotechnology industry within the broader Orthopedic, Prosthetic & Surgical Appliances & Supplies sector and is listed on the NASDAQ. In monthly performance, the stock ranks #1,549 among all tracked companies.

Frequently Asked Questions

What is the current stock price of CONEXEU SCIENCES (CNXU)?

The current stock price of CONEXEU SCIENCES (CNXU) is $9.5 as of July 14, 2026.

What is the market cap of CONEXEU SCIENCES (CNXU)?

The market cap of CONEXEU SCIENCES (CNXU) is approximately 276.7M. Learn more about what market capitalization means .